| dc.creator | Marin D.M. | |
| dc.creator | De Barros-Mazon S. | |
| dc.creator | Alegre S.M. | |
| dc.date | 2010 | |
| dc.date | 2015-06-26T12:41:54Z | |
| dc.date | 2015-11-26T15:30:29Z | |
| dc.date | 2015-06-26T12:41:54Z | |
| dc.date | 2015-11-26T15:30:29Z | |
| dc.date.accessioned | 2018-03-28T22:38:57Z | |
| dc.date.available | 2018-03-28T22:38:57Z | |
| dc.identifier | 9781608768295 | |
| dc.identifier | Insulin Resistance: Symptoms, Causes And Treatment. Nova Science Publishers, Inc., v. , n. , p. 105 - 128, 2010. | |
| dc.identifier | | |
| dc.identifier | | |
| dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-84895313115&partnerID=40&md5=1bdd68487923126dfee628493bedbb4a | |
| dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/91495 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/91495 | |
| dc.identifier | 2-s2.0-84895313115 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1261999 | |
| dc.description | Insulin secretion is regulated mainly by glucose stimulus changes and is characterized by first and second phase (biphasic time course). β-cell glucose sensitivity is essential to maintain glucose homeostasis and loss of that capacity has been related to progression from normal glucose tolerance to impaired glucose tolerance and diabetes mellitus. β-cell glucose sensitivity can be evaluated through a slope of dose-response curve which shows the ability to increase insulin release with the appropriate amount and time course to cope with acute changes in plasma glucose concentration. Some factors can modulate insulin secretion. One of them is glucose toxicity, the direct impairment of chronic hyperglycemia on β-cell function characterized as impairment in insulin response to glucose but not to other nonglucose secretagogues. A glucose-induced insulin secretion is completely restored if normoglycemia is achieved. Lipotoxicity is also related to lower glucose induced insulin secretion through different mechanisms. On the other hand, it is suggested that the incretin GLP-1 stimulates insulin secretion through increasing β-cell glucose sensitivity, inhibiting potassium channels and exacerbating the voltage-dependent calcium channels. Normoglycemia in states of insulin resistance is maintained by a compensatory increase in insulin secretion. Adipokines such as pro-inflammatory cytokines are related to insulin resistance in obesity and type 2 diabetes. The mechanisms underlying regulated-insulin secretion by adipokines and insulin resistance are very complex and not completely understood. In fact a real molecular and cellular inflammatory network takes place acting per se linking up lipotoxicity, glucotoxicity and insulin secretion. Adiponectin and weight loss, on the other hand, are related to the decrease in the pro-inflammatory state and improved insulin action and secretion. So the focus of this review is to address the mechanisms underlying reciprocal relationships between insulin secretion, insulin resistance and inflammation in the pathological state and in its subsequent improvement. © 2010 by Nova Science Publishers, Inc. All rights reserved. | |
| dc.description | | |
| dc.description | | |
| dc.description | 105 | |
| dc.description | 128 | |
| dc.description | Caumo, A., Luzi, L., First-phase insulin secretion: does it exist in real life? Considerations on shape and function (2004) Am J Physiol Endocrinol Metab, 287, pp. E371-E385 | |
| dc.description | Brunzell, J.D., Robertson, R.P., Lerner, R.L., Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests (1976) J Clin Endocrinol Metab, 42, pp. 222-229 | |
| dc.description | Jones, C.N.O., Abbasi, F., Carantoni, M., Roles of insulin resistance and obesity in regulation of plasma insulin concentrations (2000) Am J Physiol, 278, pp. E501-508 | |
| dc.description | Weyer, C., Bogardus, C., Mott, D.M., Pratley, R.E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus (1999) J Clin Invest, 104, pp. 787-794 | |
| dc.description | Abdul-Ghani, M.A., Tripathy, D., De Fronzo, R.A., Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose (2006) Diabetes Care, 29, pp. 1130-1139 | |
| dc.description | UK prospective diabetes study 7: Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients (1990), 39 (9), pp. 905-912. , UKPDS Group. MetabolismSjöström, C.D., Lissner, L., Wedel, H., Sjöström, L., Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study (1999) Obes Res., 7, pp. 477-484 | |
| dc.description | Diabetes Prevention Program Research Group (2002) N Engl J Med., 346, pp. 393-403. , Reduction in the Incidence of Type2 Diabetes with Lifestyle Intervention or Metformin | |
| dc.description | Muscelli, E., Mingrone, G., Camastra, S., Manco, M., Pereira, J.A., Pareja, J.C., Ferrannini, E., Differential effect of weight loss on insulin resistance in surgically treated obese patients (2005) Am J Med, 118 (1), pp. 51-57 | |
| dc.description | Cerasi, E., Luft, R., Efendic, S., Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study (1972) Diabetes, 21, pp. 224-234 | |
| dc.description | Malaisse, W.J., Sener, A., Herchuelz, A., Hutton, J.C., Insulin release: the fuel hypothesis (1979) Metabolism, 28, p. 373 | |
| dc.description | Levin, S.R., Karam, J.H., Hane, S., Enhancement of arginine-induced insulin secretion in man by prior administration of glucose (1971) Diabetes, 20, pp. 171-176 | |
| dc.description | Calles-Escandon, J., Robbins, D.C., Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose (1987) Diabetes, 36, pp. 1167-1172 | |
| dc.description | Cerasi, E., Luft, R., The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus (1967) Acta Endocrinol, 55, pp. 278-304 | |
| dc.description | Lefebre, P.J., Paolisso, G., Scheen, A.J., Henquin, J.C., Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications (1987) Diabetologia, 30, pp. 443-452 | |
| dc.description | Porksen, N., The in vivo regulation of pulsatile insulin secretion (2002) Diabetologia, 45, pp. 3-20 | |
| dc.description | Steiner, K.E., Mouton, S.M., Williams, P.E., Lacy, W.W., Cherrington, A.D., Relative importance of first and second-phase insulin secretion on glucose homeostasis in conscious dog (1986) Diabetes, 35, pp. 776-784 | |
| dc.description | Unger, R.H., Glucagon physiology and pathophysiology in the light of new advances (1985) Diabetologia, 28, pp. 574-578 | |
| dc.description | Nauck, M.A., Homberger, E., Eberhard, G.S., Allen, R.C., Eaton, R.P., Ebert, R., Creutzfeldt, W., Incretin effects oj increasing glucose loads in man calculated from venous insulin and c-peptide responses (1986) J Clin Endocrinol Metab, 63, pp. 492-498 | |
| dc.description | Kjems, L.L., Holst, J.J., Vølund, A., Madsbad, S., The influence of GLP-1 on glucose-stimulated insulin secretion. Effects on β-cell sensitivity in type 2 and nondiabetic subjects (2003) Diabetes, 52, pp. 380-386 | |
| dc.description | Gromada, J., Ding, W.G., Barg, S., Renstrom, E., Rorsman, P., Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors (1997) Pflugers Arch, 434, pp. 515-521 | |
| dc.description | Gromada, J., Bokvist, K., Ding, W.G., Holst, J.J., Nielsen, J.H., Rorsman, P., Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling (1998) Diabetes, 47, pp. 57-65 | |
| dc.description | Drucker, D.J., The role of gut hormones in glucose homeostasis (2007) J Clin Invesy, 117, pp. 24-32 | |
| dc.description | Drucker, D.J., The biology of incretin hormones (2006) Cell Metab, 3, pp. 153-165 | |
| dc.description | Holz, G.G., Habener, J.F., Signal transduction cross-talk in the endocrine system: pancreatic beta-cells and the glucose competence concept (1992) Trends Biochem Sci, 17, pp. 388-393 | |
| dc.description | Drucker, D.J., Biological actions and therapeutic potential of th glucagon-like peptide (2002) Gastroenterology, 122, pp. 531-544 | |
| dc.description | Brubaker, P.L., Drucker, D.J., Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1 and GLP-2 receptors (2002) Receptors Channels, 8, pp. 179-188 | |
| dc.description | Gerich, J.E., Oral hypoglycemic agents (1989) N Engl J Med, 321, pp. 1231-1245 | |
| dc.description | Drucker, D.J., Enhancing incretin action for the treatment of type 2 diabetes (2003) Diabetes Care, 26, pp. 2928-2940 | |
| dc.description | Perfetti, R., Merkel, P., Glucagon-like peptide-1: a major regulator of pancreatic-cell function (2000) Eur J Endocrinol, 143, pp. 717-725 | |
| dc.description | Cherrington, A.D., Edgerton, D., Sindelat, D.K., The direct and indirect effects of insulin on hepatic glucose production in vivo (1998) Diabetologia, 41, pp. 987-996 | |
| dc.description | Steiner, K.E., Mouton, S.M., Bowles, C.R., Williams, P.E., Cherrington, A.D., The relative importance of first and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog (1982) Diabetes, 31, pp. 964-972 | |
| dc.description | Toffolo, G., De Grandi, F., Cobelli, C., Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion (1995) Diabetes, 44, pp. 845-854 | |
| dc.description | Kahn, S.E., Prigeon, R.L., McCulloch, D.K., Boyko, E.J., Bergman, R.N., Schwartz, M.W., Neifing, J.L., Palmer, J.P., Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function (1993) Diabetes, 42, pp. 1663-1672 | |
| dc.description | Mari, A., Schmitz, O., Gastaldelli, A., Oestergaard, T., Nyholm, B., Ferrannini, E., Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects (2002) Am J Physiol Endocrinol Metab, 283, pp. E 1159-E 1166 | |
| dc.description | Ahrén, B., Pacini, G., Importance of quantifying insulinsecretion in relation to insulin sensitivity to accurately assess beta-cell function in clinical studies (2004) Eur J Endocrinol, 150, pp. 97-104 | |
| dc.description | Stumvoll, M., Tataranni, A., Stefan, N., Vozarova, B., Bogardus, C., Glucose allostasis (2003) Diabetes, 52, pp. 903-909 | |
| dc.description | Bergman, R.N., Ader, M., Huecking, K., Van Citters, G., Accurate assessment of beta-cell function: the hyperbolic correction (2002) Diabetes, 51 (SUPPL. 1), pp. s212-s220 | |
| dc.description | Mari, A., Ahrén, B., Pacini, G., Assessment of insulin secretion in relation to insulin resistance (2005) Curr Opin in Clin Nutr and Metab Care, 8, pp. 529-533 | |
| dc.description | Unwin, N., Shaw, J., Zimmet, P., Alberti, K.G.M.N., Impaired glucose tolerance and impaired fasting glicemia: the current satatus on definition and intervention (2002) Diabet Med, 19, pp. 708-723 | |
| dc.description | Buchanan, T.A., Xiang, A.H., Peters, R.K., Kjos, S.L., Marroquin, A., Goico, J., Ochoa, C., Azen, S.P., Preservation of pancreatic B cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women (2002) Diabetes, 51, pp. 2796-2803 | |
| dc.description | Ferrannini, E., Camastra, S., Gastaldelli, A., Sironi, A.M., Natali, A., Muscelli, E., Mingrone, G., Mari, A., Beta-Cell function in obesity. Effects of weight loss (2004) Diabetes, 53 (SUPPL. 3), pp. s26-s33 | |
| dc.description | Kitabchi, A.E., Temprosa, M., Knowler, W.C., Kahn, S.E., Fowler, S.E., Haffner, S.M., Andres, R., Shamoon, H., The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin (2005) Diabetes, 54, pp. 2404-2414 | |
| dc.description | Ahrén, B., Pacini, G., Impaired adaptation of first-phase insulin secretion in post-menopausal women with glucose intolerance (1997) Am J Physiol, 36, pp. E701-E707 | |
| dc.description | Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., De Fronzo, R.A., San Antonio Metabolism study: beta-cell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) study (2004) Diabetologia, 47, pp. 31-39 | |
| dc.description | Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., De Fronzo, R.A., β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis (2005) J Clin Endocrinol Metab, 90 (1), pp. 493-500 | |
| dc.description | Efendic, S., Cerasi, E., Luft, R., Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in health, prediabetic, and diabetic subjects (1974) Diabetes, 23, pp. 161-171 | |
| dc.description | Novoa, F.J., Boronat, M., Saavedra, P., Diaz-Cremades, J.M., Varillas, V.F., La Roche, F., Alberiche, M.P., Carrillo, A., Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study (2005) Diabetes Care, 28, pp. 2388-2393 | |
| dc.description | Pfeifer, M.A., Halter, J.B., Porte Jr, D.., Insulinsecretion in diabetes mellitus (1981) Am J Med, 70, pp. 579-588 | |
| dc.description | Ward, W.K., Bolgiano, D.C., McKnight, B., Diminished-cell secretory capacity in patients with non-insulin dependent diabetes mellitus (1984) J Clin Invest, 74, pp. 1318-1328 | |
| dc.description | Byrne, M.M., Sturis, J., Sobel, R.J., Elevated plasma glucose 2h posthallenge predicts defects in β-cell function (1996) Am J Physiol, 270, pp. E572-E579 | |
| dc.description | Bergman, R.N., Phillips, L.S., Cobelli, C., Physiological evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose (1981) J Clin Invest, 68, pp. 1456-1467 | |
| dc.description | Havel, J.P., Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein and adiponectin (2002) Curr Opin Lipidol, 13, pp. 51-59 | |
| dc.description | Rajala, M.W., Scherer, P.E., Minireview: the adipocyte: at the crossroads of energy homeostasis, inflamation and atherosclerosis (2003) Endocrinology, 144, pp. 3765-3773 | |
| dc.description | Ferrannini, E., Barrett, E.J., Bevilacqua, S., DeFronzo, R.A., Effect of free fatty acids on glucose production and utilization in man (1983) J Clin Invest, 72, pp. 1737-1745 | |
| dc.description | Nolan, C.J., Madiraju, M.S.R., Delghingaro-Augusto, V., Peyot, M.L., Prentki, M., Fatty Acid Signaling in the ß Cell and Insulin Secretion (2006) Diabetes, 55 (SUPPL. 2), pp. S16-S23 | |
| dc.description | Zhou, Y.P., Grill, V.E., Palmitate-induced beta-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets (1995) Diabetes, 44, pp. 394-399 | |
| dc.description | Kashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Bervia, R., Pratipanawart, N., Bajaj, M., Cusi, K., A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes (2003) Diabetes, 52, pp. 2461-2474 | |
| dc.description | Roden, M., Price, T.B., Perseghin, G., Mechanism of free fatty acid induced insulin resistance in humans (1996) J Clin Invest, 97, pp. 2859-2865 | |
| dc.description | Roden, M., Krssak, M., Stingl et, al., Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans (1999) Diabetes, 48, pp. 385-364 | |
| dc.description | Dresner, A., Laurent, D., Marcucci, M., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol3-kinase activity (1999) J Clin Invest, 103, pp. 253-259 | |
| dc.description | Krebs, M., Krssab, M., Nonotny, P., Free fatty acids inhibit the glucose-stimulate increase of intramuscular glucose-6-phosphate concentration in humans (2001) J Clin Endocrinol Metab, 86, pp. 2153-2160 | |
| dc.description | Schulman, G.I., Cellular mechanisms of insulin resistance (2000) J Clin Invest, 106, pp. 171-176 | |
| dc.description | Randle, P.J., Hales, C.N., Garland, P.B., Newsholme, E.A., The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus (1963) Lancet, 1, pp. 758-789 | |
| dc.description | Garvey, W.T., Birnbaum, M., Cellular insulin action and insulin resistance (1993) Clin Endocrinol Metab, 7 (4), pp. 785-873. , Ed: Ferrannini E | |
| dc.description | Yu, C., Chen, Y., Cline, G.W., Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 [IRS-1] associated phosphatidylinositol 3-kinase activity in muscle (2002) J Biol Chem, 277, pp. 50230-50236 | |
| dc.description | Ellis, B.A., Poynten, A., Lowy, A.J., Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle (2000) Am J Physiol, 279, pp. E554-E560 | |
| dc.description | Dresner, A., Laurent, D., Marcucci, M., Griffin, M.E., Dufour, S., Cline, G.W., Slezak, L.A., Shulman, G.I., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity (1999) The Journal Clin Invest, 103, pp. 253-259 | |
| dc.description | White, M.F., Insulin signaling in health and disease (2003) Science, 302 (5651), pp. 1710-1711 | |
| dc.description | Nguyen, M.T., Satoh, H., Favelyukis, S., Babendure, J.L., Imamura, T., Sbodio, J.I., Zalevsky, J., Olefsky, J.M., JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes (2005) J Biol Chem, 280, pp. 35361-35371 | |
| dc.description | Gremlich, S., Bonny, C., Waeber, G., Thorens, B., Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels (1997) J Biol Chem, 272, pp. 30261-30269 | |
| dc.description | Robertson, R.P., Harmon, J., Tran, P.O., Poitout, V., β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes (2004) Diabetes, 53 (SUPPL. 1), pp. S119-S124 | |
| dc.description | Leahy, J.L., Cooper, H.E., Deal, D.A., Weir, G.C., Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: a study in normal rats using chronic in vivo glucose infusions (1986) J. Clin. Invest, 77, pp. 908-991 | |
| dc.description | Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P., Colette, C., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes (2006) JAMA, 295, pp. 1681-1687 | |
| dc.description | Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H.I., Spinas, G.A., Kaiser, N., Donath, M.Y., Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets (2002) J Clin Invest, 110, pp. 851-860 | |
| dc.description | Robertson, R.P., Zhang, H.J., Pyzdrowski, K.L., Walseth, T.F., Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations (1992) J. Clin. Invest, 90, pp. 320-325 | |
| dc.description | Dubois, M., Vacher, P., Roger, B., Huyghe, D., Vandewalle, B., Kerr-Conte, J., Pattou, F., Lang, J., Glucotoxicity Inhibits Late Steps of Insulin Exocytosis (2007) Endocrinology, 148, pp. 1605-1614 | |
| dc.description | Tajiri, Y., Moller, C., Grill, V., Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function (1997) Endocrinology, 138, pp. 273-280 | |
| dc.description | Spinas, G.A., Palmer, J.P., Mandrup-Poulsen, T., Andersen, H., Nielsen, J.H., Nerup, J., The bimodal effect of interleukin 1 on rat pancreatic β-cells-stimulation followed by inhibition-depends upon dose, duration of exposure, and ambient glucose concentration (1988) Acta Endocrinol (Copenh), 119, pp. 307-311 | |
| dc.description | Böni-Schnetzler, M., Thorne, J., Parnaud, G., Marselli, L., Ehses, J.A., Kerr-Conte, J., Pattou, F., Donath, M.Y., Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation (2008) J Clin Endocrinol Metab, 93 (10), pp. 4065-4074 | |
| dc.description | Maedler, K., Schulthess, F.T., Bielman, C., Berney, T., Bonny, C., Prentki, M., Donath, M.Y., Roduit, R., Glucose and leptin induce apoptosis in human β-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases (2008) The FASEB Journal, 22, p. 1905 | |
| dc.description | Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia (2001) J Clin Endocrinol Metab, 86 (5), pp. 1930-1935 | |
| dc.description | Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E., Rossetti, L., Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 (2001) The Journal of Clinical Investigation, 108 (12), pp. 1875-1881 | |
| dc.description | Fruebis, J., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice (2001) Proc Natl Acad Sci, 98, pp. 2005-2010 | |
| dc.description | Abbasi, F., Chu, J.W., Lamendola, C., McLaughlin, T., Hayden, J., Reaven, G.M., Reaven, P.D., Discrimination between obesity and insulin resistance in the relationship with adiponectin (2004) Diabetes, 53, pp. 585-590 | |
| dc.description | Kharroubi, I., Rasschaert, J., Eizirik, D.L., Cnop, M., Expression of adiponectin receptors in pancreatic b cells (2003) Biochemical and Biophysical Research Communications, 312, pp. 1118-1122 | |
| dc.description | Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., Eckel, J., Adiponectin counteracts cytokine-and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1 (2004) Diabetologia, 47, pp. 249-258 | |
| dc.description | Staiger, K., Stefan, N., Staiger, H., Brendel, H.D., Brandhorst, D., Bretzel, R.G., Machicao, F., Häring, H.U., Adiponectin Is Functionally Active in Human Islets but Does Not Affect Insulin Secretory Function or β-Cell Lipoapoptosis (2005) J Clin Endocrinol Metab, 90, pp. 6707-6713 | |
| dc.description | Kern, P.A., Ranganathan, S., Li, C., Wood, L., Ranganathan, G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance (2001) Am J Physiol Endocrinol Metab, 280 (5), pp. E745-51 | |
| dc.description | Liu, L.S., Spelleken, M., Rohrig, K., Hauner, H., Eckel, J., Tumor Necrosis factor alpha acutely inhibits insulin signalling in human adipocytes: implications of the p80 tumor necrosis factor receptor (1998) Diabetes, 47 (4), pp. 515-522 | |
| dc.description | Hotamisligil, G.S., Spiegelman, B.M., Tumor necrosis factor alpha: a key component of the obesity-diabetes link (1994) Diabetes, 43 (11), pp. 1271-1278 | |
| dc.description | Kanety, H., Feinstein, R., Papa, M.Z., Hemi, R., Karasik, A., Tumor necrosis factor alpha induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1 (1995) The Journal of Biological Chemistry, 270 (40), pp. 23780-23784 | |
| dc.description | Hauner, H., Petruschke, T., Russ, M., Rohrig, K., Eckel, J., Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture (1995) Diabetologia, 38, pp. 764-771 | |
| dc.description | Zhang, H.H., Halbleib, M., Ahmad, F., Manganiello, V.C., Greenberg, A.S., Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP (2002) Diabetes, 51, pp. 2929-2935 | |
| dc.description | Maeda, N., Shimomura, I., Kishida, K., Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 (2002) Nat Med, 8, pp. 731-737 | |
| dc.description | Wang, B., Jenkins, J.R., Trayhurn, P., Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha (2005) Am J Physiol Endocrinol Metab, 288, pp. E731-E740 | |
| dc.description | Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., Ridker, P.M., C-reactive protein, interleukin 6, and risk of developing type 2 Diabetes Mellitus (2001) JAMA, 286 (3), pp. 327-334 | |
| dc.description | Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha in vivo (1997) J Clin Endocrinol Metab, 82 (12), pp. 4196-4200 | |
| dc.description | Ortiz, J.N.M., Monte Alegre, S., Marin, D.M., Souza, A.L., Pareja, J.C., Muscelli, E., The effect of insulin on serum adiponectin, IL-6, TNF-α and CRP in severely obese subjects with normal or impaired glucose tolerance-unpublished data Dixon, J.B., O'Brien, P.E., Lipid profile in the severely obese: changes with weight loss after lap-band surgery (2002) Obesity Research, 10 (9), pp. 903-910 | |
| dc.description | Pereira, J.A., Claro, B.M., Pareja, J.C., Chaim, E.A., Astiarraga, B.D., Saad, M.J., Muscelli, E., Restored insulin inhibition on insulin secretion in nondiabetic severely obese patients after weight loss induced by bariatric surgery (2003) International Journal of Obesity, 27, pp. 463-468 | |
| dc.description | Pereira, J.A., Lararin, M.A.C.T., Pareja, J.C., Souza, A.L., Mescelli, E., Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery (2003) Obesity Research, 11, pp. 1495-1501 | |
| dc.description | Korner, J., Bessler, M., Cirilo, L.J., Conwell, I.M., Daud, A., Restuccia, N.L., Wardlaw, S.L., Effects of Roux-en-Y Gastric Bypass Surgery on Fasting and Postprandial Concentrations of Plasma Ghrelin, Peptide YY, and Insulin (2005) The Journal of Clinical Endocrinology & Metabolism, 90 (1), pp. 359-365 | |
| dc.description | Shah, M., Simha, V., Garg, A., Long-term impact of bariatric surgery on body weight, comorbidities and nutritional status (2006) Journal of Clin Endocrinol & Metab, 91 (11), pp. 4223-4231 | |
| dc.description | Pories, W.J., Macdonald, K.G., Morgan, E.J., Surgical treatment of obesity and its effects on diabetes: 10-y follow-up (1992) Am J Clin Nutr, 55, pp. 582S-585S | |
| dc.description | Buchwald, H., Avidor, Y., Brawnwald, E., Bariatric surgery: a systemic review and meta-analysis (2004) JAMA, 2992, pp. 1724-1737 | |
| dc.description | Guldstrand, M., Ahrén, B., Adamson, A.U., Improved β-cell function after standardized weight reduction in severely obese subjects (2003) Am J Physiol Endocrinol Metab, 284, pp. E557-E565 | |
| dc.description | Marin, D.M., Monte Alegre, S., Ortiz, J.N.M., Pareja, J.C., Chaim, E.A., Silva, C.A., Astiarraga, B.D., Muscelli, E., Insulin secretion and β-cell glucose sensitivity in Severe Obesity: Effect of Weight Loss after Gastric bypass-unpublished data Mari, A., Manco, M., Guidone, C., Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function (2006) Diabetologia, 49 (9), pp. 2136-2143 | |
| dc.description | Guidone, C., Manco, M., Valera-Mora, E., Mechanisms of recovery from type 2 diabetes after malabsorptive batiatric surgery (2006) Diabetes, 55, pp. 2025-2031 | |
| dc.description | Patriti, A., Facchiano, E., Sanna, A., Gulla, N., Donini, A., The enteroinsular axis and the recovery from type2 diabetes after bariatric surgery (2004) Obes Surg, 14, pp. 840-848 | |
| dc.description | Ahren, B., Holst, J.J., Mari, A., Characterization of GLP-1 effects on-cell function after meal ingestion in humans (2003) Diabetes Care, 26, pp. 2860-2864 | |
| dc.description | Nauck, A., Heinesaat, M.M., Orkor, C., Preserved incretin activity of synthetic human gastric inhibitory polypeptide in patients with type 2 diabetes (1993) J Clin Invest, 91, pp. 301-307 | |
| dc.description | Blandine, L., Stanley, H., Krystle, W., Incretin levels and effect are markedly enhanced 1 month after Roux-in-Y gastric bypass surgery in obese patients with type 2 diabetes (2007) Diabetes Care, 30, pp. 1709-1716 | |
| dc.description | Carvalho, C.P., Marin, D.M., Souza, A.L., Pareja, J.C., Chaim, E.A., de Barros-Mazon, S., Silva, C.A., Monte Alegre, S., GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism (2009) Obes Surg, 19 (3), pp. 313-320 | |
| dc.description | Donath, M.Y., Størling, J., Berchtold, L.A., Billestrup, N., Mandrup-Poulsen, T., Cytokines and beta-cell biology: from concept to clinical translation (2008) Endocr Rev, 29 (3), pp. 334-350 | |
| dc.description | Larsen, C.M., Faulenbach, M., Vaag, A., Volund, A., Ehses, J.A., Seifert, B., Mandrup-Poulsen, T., Donath, M.Y., Interleukin-1-receptor antagonist in type 2 diabetes mellitus (2007) N Engl J Med, 356, pp. 1517-1526 | |
| dc.description | Larsen, C.M., Faulenbach, M., Vaag, A., Ehses, J.A., Donath, M.Y., Mandrup-Poulsen, T., Sustained Effects of Interleukin-1-Receptor Antagonist Treatment in Type 2 Diabetes Mellitus (2009) Diabetes Care, , [Epub ahead of print] | |
| dc.description | Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H.I., Spinas, G.A., Kaiser, N., Donath, M.Y., Glucose-induced beta-cell production of interleukin-1 contributes to glucotoxicity in human pancreatic islets (2002) J. Clin.Invest, 110, pp. 851-860 | |
| dc.description | Weyer, C., Bogardus, C., Mott, D.M., Pratley, R.E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus (1999) J Clin Invest, 104, pp. 787-794 | |
| dc.description | Kitabchi, A.E., Temprosa, M., Knowler, W.C., Kahn, S.E., Fowler, S.E., Haffner, S.M., Andres, R., Shamoon, H., The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program:effects of lifestyle intervention and metformin (2005) Diabetes, 54, pp. 2404-2414 | |
| dc.language | en | |
| dc.publisher | Nova Science Publishers, Inc. | |
| dc.relation | Insulin Resistance: Symptoms, Causes and Treatment | |
| dc.rights | fechado | |
| dc.source | Scopus | |
| dc.title | Insulin Secretion In Insulin Resistance States | |
| dc.type | Capítulos de libros | |
